Select for export A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-05-14 University of Wisconsin, Madison ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyAddiction Clinical Trial More
Select for export Psychedelic Medicine: From Brain Science to Clinical Trials No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2023.02.022 Copy citation Copy BibTeX Biological Psychiatry 2023-04-09 David Nutt OpenAlex Published psilocybin AddictionBrain ImagingReceptor Pharmacology Clinical Trial More
Select for export [Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1254/fpj.22141 PubMed 36990794 Copy citation Copy BibTeX Unknown journal 2023-03-28 Ibi D. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/cells12060963 PubMed 36980303 Copy citation Copy BibTeX Unknown journal 2023-03-21 Domanegg K, Sommer WH, Meinhardt MW. Europe PMC Published psilocybin AddictionNeuroplasticityMechanism of Action Clinical Trial More
Select for export How psychedelics spark neuronal growth Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-10108-scicon1 Copy citation Copy BibTeX C&EN Global Enterprise 2023-03-05 Shi En Kim OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Other More
Select for export Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0963180123000099 PubMed 36861394 Copy citation Copy BibTeX Cambridge Quarterly of Healthcare Ethics 2023-03-01 Nathan Emmerich, Bryce Humphries OpenAlex Published psilocybin DepressionPTSDAddiction Other More
Select for export Interaction of psychedelic tryptamine derivatives with a lipid bilayer. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.chemphyslip.2023.105279 PubMed 36627076 Copy citation Copy BibTeX Chemistry and physics of lipids 2023-02-28 Zohairi F, Khandelia H, Hakami Zanjani AA PubMed Published psilocin DepressionAnxietyAddiction Other More
Select for export The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31275/20222633 Copy citation Copy BibTeX Journal of Scientific Exploration 2023-02-10 Jeffery Heilman OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export The therapeutic potential of psychedelics: the European regulatory perspective No abstract availability was recorded for this entry. Details DOI 10.1016/s0140-6736(23)00264-7 PubMed 36780909 Copy citation Copy BibTeX The Lancet 2023-02-10 Florence Butlen-Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp, Taina Mattila, Ewa Bałkowiec-Iskra, Georgios Aislaitner OpenAlex Published psilocybin Addiction Other More
Select for export Therapeutic effect of psilocybin in addiction: A systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1134454 PubMed 36846225 Copy citation Copy BibTeX Unknown journal 2023-02-08 van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE Europe PMC Published psilocybin AddictionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export The association between naturalistic use of psychedelics and co-occurring substance use disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2022.1066369 PubMed 36704738 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-01-09 Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross OpenAlex Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2023-01-03 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Psychedelic Drug Therapy for Mental Disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4236/ojmp.2023.123010 Copy citation Copy BibTeX Open Journal of Medical Psychology 2022-12-31 John R. Rossiter OpenAlex Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnins.2023.1156319 PubMed 37139521 Copy citation Copy BibTeX Frontiers in neuroscience 2022-12-31 Urban MM, Stingl MR, Meinhardt MW PubMed Published psilocybin AddictionNeuroplasticityMechanism of Action Review Article More
Select for export Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyt.2023.1305478 PubMed 37928914 Copy citation Copy BibTeX Frontiers in psychiatry 2022-12-31 Barnett BS, Bassir Nia A, Sackett NB, Weleff J PubMed Published psilocybin AddictionMechanism of ActionSafety Other More
Select for export Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1227/neu.0000000000002275 PubMed 36512813 Copy citation Copy BibTeX Unknown journal 2022-12-07 Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11064-022-03772-0 PubMed 36327017 Copy citation Copy BibTeX Unknown journal 2022-11-02 VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. Europe PMC Published psilocybin AddictionNeuroplasticityPharmacology Review Article More
Select for export Potential Therapeutic Effects of Psilocybin: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.30214 PubMed 36381758 Copy citation Copy BibTeX Unknown journal 2022-10-11 Goel DB, Zilate S. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Towards an understanding of psychedelic-induced neuroplasticity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-022-01389-z PubMed 36123427 Copy citation Copy BibTeX Unknown journal 2022-09-18 Calder AE, Hasler G. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Effective connectivity of emotion and cognition under psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.09.06.22279626 Copy citation Copy BibTeX medRxiv 2022-09-08 Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. medRxiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionDefault Mode Network Clinical Trial More
